Manage your pharmacy inventory

Deep knowledge on
small-molecule drugs and
the global patents
covering them

Drug patents …
… from Kazakhstan to Kalamazoo

Anticipate generic drug launch

Find generic entry opportunities

Project your formulary budget

Make Better Decisions

Uncover prior art in expired and abandoned patents
Obtain formulation and manufacturing information
Drug patents in 130+ countries

► See Plans & Pricing

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 7,358,366 protect, and when does it expire?

Patent ► Subscribe protects AVANDARYL, AVANDAMET, and AVANDIA, and is included in three NDAs. There have been zero Paragraph IV challenges on Avandaryl and

Protection for AVANDARYL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: ► Subscribe

Title:	Thiazolidinedione derivative and its use as antidiabetic
Abstract:	A polymorphic form of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione- , maleic acid salt (the "Polymorph") characterised in that it provides: (i) an infra red spectrum containing peaks at 1752, 1546, 1154, 621, and 602 cm.sup.-1; and/or (ii) a Raman spectrum containing peaks at 1751, 1243 and 602 cm.sup.-1; and/or (iii) a solid-state nuclear magnetic resonance spectrum containing peaks at 111.9, 114.8, 119.6, 129.2, 134.0, 138.0, 144.7, 153.2, 157.1, 170.7, 172.0, and 175.0 ppm; and/or (iv) an X-ray powder diffraction (XRPD) pattern which gives calculated lattice spacings of 6.46, 5.39, 4.83, 4.68, 3.71, 3.63, 3.58, and 3.48 Angstroms; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Inventor(s):	Blackler; Paul David James (Cadiz, ES), Giles; Robert Gordon (Tonbridge, GB), Moore; Stephen (Tonbridge, GB), Sasse; Michael John (Tonbridge, GB)
Assignee:	SmithKline Beecham p.l.c. (Brentford, Middlesex, GB)
Application Number:	11/458,471
Patent Claim Types: see list of patent claims	Compound;

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	RS	Patent No.	Patent Expiration	Delist Req.
Sb Pharmco	AVANDARYL	glimepiride; rosiglitazone maleate	TABLET;ORAL	021700-001	Nov 23, 2005	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDARYL	glimepiride; rosiglitazone maleate	TABLET;ORAL	021700-002	Nov 23, 2005	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDARYL	glimepiride; rosiglitazone maleate	TABLET;ORAL	021700-004	Mar 30, 2007	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDARYL	glimepiride; rosiglitazone maleate	TABLET;ORAL	021700-003	Nov 23, 2005	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDARYL	glimepiride; rosiglitazone maleate	TABLET;ORAL	021700-005	Mar 30, 2007	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDAMET	metformin hydrochloride; rosiglitazone maleate	TABLET;ORAL	021410-004	Aug 25, 2003	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDAMET	metformin hydrochloride; rosiglitazone maleate	TABLET;ORAL	021410-005	Aug 25, 2003	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDAMET	metformin hydrochloride; rosiglitazone maleate	TABLET;ORAL	021410-001	Oct 10, 2002	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDAMET	metformin hydrochloride; rosiglitazone maleate	TABLET;ORAL	021410-002	Oct 10, 2002	DISCN	Yes	No	► Subscribe	► Subscribe	Y
Sb Pharmco	AVANDAMET	metformin hydrochloride; rosiglitazone maleate	TABLET;ORAL	021410-003	Oct 10, 2002	DISCN	Yes	No	► Subscribe	► Subscribe	Y

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9909471.6	Apr 23, 1999
United Kingdom	9912195.6	May 25, 1999

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.